Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Pin Huang

Showing results (101-110 of 214) with videos related to

Pageof 22
Sort By:
The Kaohsiung Journal of Medical Sciences|January 15, 2008
Laparoscopic partial nephrectomy: the effect of preoperative tumor embolizationChing-Chia Li, Yii-Her Chou, Wen-Jeng Wu, et al.
The International Journal of Biological Markers|September 30, 2009
Downregulation of ABCD1 in human renal cell carcinomaTzyh-Chyuan Hour, Yi-Zih Kuo, Guang-Yan Liu, et al.
Plos One|April 16, 2015
Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based studyChia-Chu Liu, Hui-Min Hsieh, Chia-Fang Wu, et al.
Cancer Genomics & Proteomics|April 24, 2021
<i>PTBP1</i> Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate CancerShu-Pin Huang, Lih-Chyang Chen, Yei-Tsung Chen, et al.
Cancer Medicine|July 8, 2026
Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based StudyJiun-Hung Geng, Chia-Cheng Yu, Chao-Yuan Huang, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Interplay Between Type 2 Diabetes Susceptibility and Prostate Cancer Progression: Functional Insights into <i>C2CD4A</i>Yei-Tsung Chen, Chi-Fen Chang, Lih-Chyang Chen, et al.
European Urology Open Science|January 19, 2026
Mapping of QLQ-C30 and QLQ-PR25 Scores to EQ-5D-5L Utility Values for Patients with Prostate Cancer Receiving Novel Androgen Receptor Signaling InhibitorsShao-Yuan Hao, Shu-Pin Huang, Ching-Chia Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2012
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progressionÉric Lévesque, Shu-Pin Huang, Étienne Audet-Walsh, et al.
Cancer Medicine|August 16, 2024
The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cellsChieh Huo, Ying-Yu Kuo, Ching-Yu Lin, et al.
The Kaohsiung Journal of Medical Sciences|January 8, 2003
Adrenal tumors: 10-year experience at Kaohsiung Medical University Hospital and literature reviewShu-Pin Huang, Yii-Her Chou, Ming-Tsang Wu, et al.
Pageof 22

Showing results (101-110 of 214) with videos related to

Sort By:
Pageof 22
The Kaohsiung Journal of Medical Sciences|January 15, 2008
Laparoscopic partial nephrectomy: the effect of preoperative tumor embolizationChing-Chia Li, Yii-Her Chou, Wen-Jeng Wu, et al.
The International Journal of Biological Markers|September 30, 2009
Downregulation of ABCD1 in human renal cell carcinomaTzyh-Chyuan Hour, Yi-Zih Kuo, Guang-Yan Liu, et al.
Plos One|April 16, 2015
Long-term prescription of α-blockers decrease the risk of recurrent urolithiasis needed for surgical intervention-a nationwide population-based studyChia-Chu Liu, Hui-Min Hsieh, Chia-Fang Wu, et al.
Cancer Genomics & Proteomics|April 24, 2021
<i>PTBP1</i> Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate CancerShu-Pin Huang, Lih-Chyang Chen, Yei-Tsung Chen, et al.
Cancer Medicine|July 8, 2026
Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based StudyJiun-Hung Geng, Chia-Cheng Yu, Chao-Yuan Huang, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Interplay Between Type 2 Diabetes Susceptibility and Prostate Cancer Progression: Functional Insights into <i>C2CD4A</i>Yei-Tsung Chen, Chi-Fen Chang, Lih-Chyang Chen, et al.
European Urology Open Science|January 19, 2026
Mapping of QLQ-C30 and QLQ-PR25 Scores to EQ-5D-5L Utility Values for Patients with Prostate Cancer Receiving Novel Androgen Receptor Signaling InhibitorsShao-Yuan Hao, Shu-Pin Huang, Ching-Chia Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2012
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progressionÉric Lévesque, Shu-Pin Huang, Étienne Audet-Walsh, et al.
Cancer Medicine|August 16, 2024
The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cellsChieh Huo, Ying-Yu Kuo, Ching-Yu Lin, et al.
The Kaohsiung Journal of Medical Sciences|January 8, 2003
Adrenal tumors: 10-year experience at Kaohsiung Medical University Hospital and literature reviewShu-Pin Huang, Yii-Her Chou, Ming-Tsang Wu, et al.
Pageof 22